Antipsychotic dose and diminished neural modulation: A multi-site fMRI study
暂无分享,去创建一个
V. Calhoun | J. Lauriello | J. Bustillo | V. Magnotta | R. Gollub | H. Bockholt | B. Ho | G. Pearlson | H. Bockholt | V. Calhoun | V. P. Clark | C. Abbott | M. Juárez | T. White | B. Ho | V. D. Calhoun | C. Abbott | M. Juárez⁎ | T. White | R. L. Gollub | G. D. Pearlson | J. Bustillo | J. Lauriello | B. Ho | H. J. Bockholt | V. Magnotta | Randy L. Gollub | Godfrey D. Pearlson | Juan Bustillo | Vincent A. Magnotta | Christopher C. Abbott | M. Juárez | Thomas W. White | R. L. Gollub
[1] P. Liddle,et al. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia. , 2004, Journal of psychiatry & neuroscience : JPN.
[2] Gabriele Ende,et al. Cortical response to motor stimulation in neuroleptic-naive first episode schizophrenics , 2000, Psychiatry Research: Neuroimaging.
[3] Jonathan D. Cohen,et al. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. , 2005, The American journal of psychiatry.
[4] L R Schad,et al. Functional magnetic resonance imaging at 1.5 T: activation pattern in schizophrenic patients receiving neuroleptic medication. , 1994, Magnetic resonance imaging.
[5] Carol A. Tamminga,et al. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia , 2005, Psychiatry Research: Neuroimaging.
[6] P. Liddle,et al. Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus , 2000, British Journal of Psychiatry.
[7] Gabriele Ende,et al. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients , 1999, Schizophrenia Research.
[8] E. Richelson,et al. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. , 1984, European journal of pharmacology.
[9] J. Callicott,et al. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine , 2004, Biological Psychiatry.
[10] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[11] Vince D. Calhoun,et al. A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data , 2009, NeuroImage.
[12] V. Calhoun,et al. Aberrant "default mode" functional connectivity in schizophrenia. , 2007, The American journal of psychiatry.
[13] L. Schad,et al. Sensorimotor Cortex and Supplementary Motor Area Changes in Schizophrenia , 1995, British Journal of Psychiatry.
[14] S. Rombouts,et al. Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.
[15] Tülay Adali,et al. Estimating the number of independent components for functional magnetic resonance imaging data , 2007, Human brain mapping.
[16] M. Buchsbaum,et al. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia , 2008, Schizophrenia Research.
[17] Deborah A. Yurgelun-Todd,et al. Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation , 2004, Psychiatry Research: Neuroimaging.
[18] G. Juckel,et al. Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation , 2010, Schizophrenia Research.
[19] N C Andreasen,et al. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.
[20] Jean-Francois Mangin,et al. What is the best similarity measure for motion correction in fMRI time series? , 2002, IEEE Transactions on Medical Imaging.
[21] J. Lieberman,et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.
[22] Niels G. Waller. The Scale for the Assessment of Negative Symptoms , 1995 .
[23] M. Egan,et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. , 2003, The American journal of psychiatry.
[24] Vincent J Schmithorst,et al. Comparison of three methods for generating group statistical inferences from independent component analysis of functional magnetic resonance imaging data , 2004, Journal of magnetic resonance imaging : JMRI.
[25] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[26] Randy L. Gollub,et al. Multi-site characterization of an fMRI working memory paradigm: Reliability of activation indices , 2010, NeuroImage.
[27] P. Liddle,et al. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change , 2002, Journal of neurology, neurosurgery, and psychiatry.
[28] G. Schuierer,et al. Subcortical overactivation in untreated schizophrenic patients: A functional magnetic resonance image finger‐tapping study , 2002, Psychiatry and clinical neurosciences.
[29] Wei Deng,et al. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging. , 2010, Archives of general psychiatry.
[30] J. Lieberman,et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.
[31] P. Riederer,et al. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder , 2006, Neurotoxicity Research.
[32] R E Litman,et al. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. , 1997, Archives of general psychiatry.
[33] H. Holcomb,et al. Clozapine but not Haloperidol Re-establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate Cortex , 2004, Neuropsychopharmacology.
[34] J. Kane,et al. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. , 2003, The Journal of clinical psychiatry.
[35] T. Barnes. A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.
[36] N. Nair,et al. The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic Patients , 1987, Journal of clinical pharmacology.
[37] J. Talairach,et al. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .
[38] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[39] E. Bullmore,et al. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] F. Chollet,et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. , 2000, Brain : a journal of neurology.
[41] R. Coppola,et al. Functional Magnetic Resonance Imaging Brain Mapping in Psychiatry: Methodological Issues Illustrated in a Study of Working Memory in Schizophrenia , 1998, Neuropsychopharmacology.
[42] W. Wirshing. Movement disorders associated with neuroleptic treatment. , 2001, The Journal of clinical psychiatry.
[43] Jürgen Winkler,et al. Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study. , 2003, Psychiatry and clinical neurosciences.
[44] Maurizio Corbetta,et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] V. Calhoun,et al. Functional neural circuits for mental timekeeping , 2007, Human brain mapping.
[46] Vince D. Calhoun,et al. Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls , 2009, NeuroImage.
[47] Stephen M. Smith,et al. Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.
[48] J. Pekar,et al. A method for making group inferences from functional MRI data using independent component analysis , 2001, Human brain mapping.
[49] L. Freire,et al. Motion Correction Algorithms May Create Spurious Brain Activations in the Absence of Subject Motion , 2001, NeuroImage.
[50] Lothar R. Schad,et al. Motor Dysfunction and Sensorimotor Cortex Activation Changes in Schizophrenia: A Study with Functional Magnetic Resonance Imaging , 1999, NeuroImage.
[51] E. Richelson. Receptor pharmacology of neuroleptics: relation to clinical effects. , 1999, The Journal of clinical psychiatry.
[52] Robert S. Astur,et al. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients , 2008, Schizophrenia Research.
[53] G. Simpson,et al. A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.
[54] Terrence J. Sejnowski,et al. An Information-Maximization Approach to Blind Separation and Blind Deconvolution , 1995, Neural Computation.
[55] S. Kapur,et al. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.
[56] J S Fowler,et al. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.
[57] M. First,et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research version (SCID-I RV) , 2002 .
[58] Carol A Tamminga,et al. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol , 2003, Biological Psychiatry.
[59] M. Morrell,et al. The Expert Consensus Guideline Series Treatment of Epilepsy , 2001, Epilepsy & Behavior.
[60] J. Kane,et al. Optimizing pharmacologic treatment of psychotic disorders , 2003 .
[61] Andreas Meyer-Lindenberg,et al. D2 Antidopaminergic Modulation of Frontal Lobe Function in Healthy Human Subjects , 2006, Biological Psychiatry.